OTCMKTS:BAYRY

7.67
0.00 (0.00%) 1d
0

Related posts

Battle of the Top Dividend ETFs : Canada
Investor Insights

This summary was created by AI, based on 1 opinions in the last 12 months.

Despite the setback from the Roundup litigation, Bayer AG seems to be on the right track with new drugs on the pharma side and plans to spin out the herbicide business. Experts believe that the stock is currently priced at an attractive level and may present a good opportunity for investors. The company's acquisition of Monsanto in 2018 has been a major factor impacting its performance, but the situation is being addressed.

Consensus
Buy
Valuation
Undervalued
TOP PICK
Bayer AG

It is priced at 50 cents on the dollar compared to its peers. In 2018 it bought Monsanto and the Roundup litigation halved the company. However it is being dealt with. It has three new drugs on the pharma side, one with no near term competitors when it comes off patent. It will probably spin out the herbicide business and sits at a very attractive price.    Buy 18  Hold 8  Sell 1

chemicals
DON'T BUY
Bayer AG
Their last quarter wasn't great; there was some positive news in their pharma pipeline. They sold assets from BASF to reduce net debt, which is now at Euros 36.5 billion. The debt-to-cash flow is still high, so they have a low credit rating. Their chemical side isn't growing. EPS are down 18%, which pressured the stock. JNJ has a better phrama pipeline and credit rating.
chemicals
BUY ON WEAKNESS
Bayer AG

On these big Chemicals you are always best to wait for an opportunity to get in. There isn't an urgent rush. This company is a monstrously big company.

chemicals
DON'T BUY
Bayer AG
Into pharmaceuticals and chemicals. Things seem to be moving along very well. Getting a little overpriced at these levels.
chemicals
Showing 1 to 4 of 4 entries
  • «
  • 1
  • »

Bayer AG(BAYRY-OTC) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Bayer AG is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Bayer AG(BAYRY-OTC) Frequently Asked Questions

What is Bayer AG stock symbol?

Bayer AG is a American stock, trading under the symbol BAYRY-OTC on the US OTC (BAYRY). It is usually referred to as OTC:BAYRY or BAYRY-OTC

Is Bayer AG a buy or a sell?

In the last year, there was no coverage of Bayer AG published on Stockchase.

Is Bayer AG a good investment or a top pick?

Bayer AG was recommended as a Top Pick by on . Read the latest stock experts ratings for Bayer AG.

Why is Bayer AG stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Bayer AG worth watching?

0 stock analysts on Stockchase covered Bayer AG In the last year. It is a trending stock that is worth watching.

What is Bayer AG stock price?

On 2024-03-27, Bayer AG (BAYRY-OTC) stock closed at a price of $7.67.